Oyinkansola Badejo Okusanya: The Woman Who Broke 34-Year Leadership Barrier at the NBA Meet Dahlia Khalifa: The Woman Leading the World Bank’s Development Agenda Across the Middle East International Chess Day: What Chess Teaches Women About Leadership, Strategy and Success Mia Mottley: Leadership, Resilience and the Rise of a Global Stateswoman 10 Reasons Why Women-Owned Businesses Are Becoming the World’s Fastest-Growing Economic Force Lupita Nyong’o: The Global Influence of an Unapologetically African Woman

Isobel Coleman Takes the Helm as CEO of the Alzheimer’s Drug Discovery Foundation

By Blossom Ukoha “I’m honored to be announced as the next CEO of the Alzheimer’s Drug Discovery Foundation. Alzheimer’s is one of the defining health challenges of our time, but we are living in a moment of real progress. The clinical pipeline is expanding, blood-based diagnostics are changing how we detect disease, and advances in AI are helping accelerate the pace of discovery. Together with growing evidence around prevention, there is new momentum in the field and real reason for hope.” With this statement, Isobel Coleman sets the tone for her new role as Chief Executive Officer of the Alzheimer’s Drug Discovery Foundation, which took effective March 23, 2026. Her appointment comes at a critical moment as Alzheimer’s research enters a phase of accelerated scientific progress. Coleman brings extensive leadership experience across government, private sector, and nonprofit institutions. Most recently, she served as Deputy Administrator of the U.S. Agency for…